A B S T R A C T In fetal animals, glucocorticoids accelerate development of the lung and cause precocious appearance of alveolar surfactant. To determine if the human lung also can respond to corticosteroids, we examined lungs of the human fetus and neonate for both cytoplasmic binding and nuclear uptake of glucocorticoids. In slices of fetal lung incubated with [3H]dexamethasone at 20C, specific macromolecular binding occurs primarily in the "cytoplasmic" fraction. After further incubation at 370C. nearly 75% of the radioactivity localizes in the "nuclear" fraction with a concentration of 0.3 pmol/mg DNA at apparent dexamethasone saturation (47 nM). The cytoplasmic receptor binds dexamethasone in vitro with high affinity (dissociation constant = 8.9 nM), and the affinity of various other steroids correlates with their glucocorticoid potency. Receptor was present in lungs of fetuses and neonates of gestational age 12-43 wk, with a mean concentration in hysterotomy specimens of 0.24 pmol sites/mg cytosol protein. Similar binding activity was present at lower concentration in fetal liver, gut, kidney, heart, muscle, and skin. Cytoplasmic receptor was not detected in lung and liver of premature infants with respiratory distress syndrome. This deficit appears to result from increased levels of endogenous steroids (mean cortisol 45.5 lsg/100 ml cytosol) as well as inactivation of receptor secondary to the illness. Thus, the lung of the human fetus and neonate contains the receptor mechanism necessary for direct responsiveness to glucocorticoids. These findings support the potential usefulness of these hormones in prevention of respiratory distress syndrome in the premature infant.
INTRODUCTION
Glucocorticoids trigger specific developmental events in a number of fetal and newborn tissues (2) (3) (4) (5) (6) . It now appears that these hormones have a similar effect during development of the fetal lung. Administration of corticosteroids to fetal lambs or rabbits causes both accelerated morphological development of the lung and precocious appearance of alveolar surfactant (7, 8) . Such treatment increases the survival rate for prematurely delivered animals.
We and others have previously reported (9, 10 ) that lungs of these fetal animals contain a specific receptor system for glucocorticoids similar to that described in well-recognized target tissues such as liver (11) , thymus (12) , cultured hepatoma (HTC)1 cells (13, 14) , lymphoid cells (15) , and fibroblasts (16) . In each of these systems the earliest known event in the interaction of glucocorticoids with their target cell is the binding of steroid by specific cytoplasmic receptor proteins. The receptor-hormone complex thus formed transfers to the nucleus, where it attaches to nuclear acceptor sites and presumably influences specific gene activity. This molecular mechanism of corticosteroid action involving receptors appears to be a necessary event in all glucocorticoid target tissues, since receptor is found in most responsive organs and is not detected in certain physiologically unresponsive tissues (17) . In addition, development of steroid resistance in cultured lymphoma cells is associated with a decrease in the concentration of cytoplasmic receptor (15) . The detection of receptor in the lungs of fetal rabbits and lambs thus indicates that this organ is capable of responding to glucocorticoids and suggests that these hormones directly influence the lung during fetal life.
In the human, development of the lung is perhaps the most critical event determining the health and survival of prematurely delivered infants. Pulmonary immaturity, expressed as a deficiency of.alveolar surfactant, is the major cause of idiopathic respiratory distress syndrome (IRDS), or hyaline membrane disease, in premature infants (18) . In view of the effects of glucocorticoids on lungs of fetal animals, it has been proposed that administration of these hormones to the human fetus at risk for premature delivery might induce alveolar surfactant and prevent IRDS. In this regard, a beneficial effect of treatment of mothers in premature labor with betamethasone, a potent synthetic glucocorticoid, has recently been reported (19) .
To determine if the human lung has the capacity to respond directly to glucocorticoids during fetal and neonatal life, we have examined specimens of lung for both cytoplasmic binding and nuclear uptake of corticosteroids. This communication reports that glucocorticoid receptor is present in human lung. We describe properties of the cytoplasmic and nuclear reactions, as well as studies of the concentration of cytoplasmic receptor in lungs of fetuses throughout gestation and of infants expiring in the neonatal period with and without IRDS.
METHODS
Specimens of human lung and other tissues were obtained after natural death of nonviable or stillborn fetuses after hysterotomy, therapeutic abortions (induced by either intravenous Pitocin [Parke, Davis & Co., Detroit, Mich.] or intrauterine prostaglandin Fa,), and spontaneous abortions, and from infants dying in the intensive care nurseries of the University of California San Francisco and Mount Zion Hospital, San Francisco. The diagnosis of IRDS in some of the last group of patients was assigned by both clinical and radiological criteria (20) . Gestational age was estimated by menstrual history, clinical assessment, and fetal crown-rump and crown-heel measurements (21) . Fetal tissues were removed at an autopsy immediately post mortem whenever possible (all hysterotomies and most abortion specimens) ; otherwise bodies were stored at 40 C for H-29 h (average 10i h) before autopsy. Tissues were removed into isotonic phosphate-buffered saline (pH 7.6) at 20C and either used within 18 h or frozen at -20'C or -700C for 1-10 days.
Glucocorticoid receptor activity was measured by the charcoal assay in cell-free cytosol fractions prepared by homogenization and ultracentrifugation as previously described in detail (9 ) were incubated in 3.5-cm diameter petri dishes with 0.75 ml of incubation medium for 10-20 h at 2'C in air.
As indicated, some dishes were then exposed for 15-120 min at 370C in 90%o air: 10% C02. Tissue slices were cooled to 20C, blotted, and homogenized in 2 vols of cold 0.02 M N-tris-(hydroxymethyl) -methyl-glycine (Tricine) -2 mM CaCl2-1 mM MgCl2 (pH 7.4) (medium 1). The pellet from a 600g centrifugation for 10 min was washed in medium 1 and in medium 1 containing 0.25 M sucrose to provide a "nuclear" fraction (9) , which contained only intact nuclei, (mostly devoid of cytoplasmic tags) and some fibrous debris on microscope examination. The nuclear pellet was resuspended in water for assay of radioactivity and DNA. The supernate from the initial 600g centrifugation was recentrifuged for 15 min at 27,000g to provide a "cytoplasmic" fraction, and macromolecular-bound steroid was assayed by the charcoal absorption procedure. The binding activity in this post-mitochondrial cytoplasmic fraction was similar to that obtained in cytosol prepared by centrifugation at 100,000g for 1 h. Radioactivity was determined in both cellular fractions by counting aliquots in a Triton-containing scintillation fluid. Quenching was measured by the external standard method. Protein concentration was determined by the method of Lowry, Rosebrough, Farr, and Randall (23), and DNA was assayed by a modification of the method of Giles and Meyers (14) .
Cortisol (and corticosterone) were measured in cytosol preparations by the competitive protein binding microassay of Murphy (24) and by the charcoal absorption assay. Samples were assayed in an ethanol extract both before and after extraction with petroleum ether to also provide an estimate of the level of progesterone and 17a-hydroxyprogesterone (24) .
RESULTS
Localization of [2H]dexamethasone in the nuclear fraction of lung slices. When slices of human fetal lung are incubated with dexamethasone, specific uptake of the steroid hormone is detected in both cytoplasmic and nuclear fractions. The uptake in both fractions at 370C as a function of the free dexamethasone concentration is illustrated in Fig. 1 . The dose-response characteristics indicate a limited uptake of labeled steroid in both fractions under these conditions with saturation approached at a dexamethasone concentration below 10' M. About three times more dexamethasone is bound in the nuclear fraction at all concentrations of free steroid at this temperature. Slices of lung incubated at only 20C for 10 h, however, accumulate hormone primarily bound to a macromolecule in the cytoplasmic fraction. After 45 min exposure at 370C there is a depletion of binding in the cytoplasmic fraction and more radioactivity appears in the nuclear fraction. In four experiments using slices of lung from fetuses of [16] [17] [18] [19] [20] Scatchard plot of the binding data (inset of Fig. 2 ) is linear, suggesting that lung cytosol contains a single class of receptor sites. In this experiment we also assayed cytosol prepared from liver of the same fetus. While the affinity of receptor in the two tissues is similar, as indicated by the slopes of the Scatchard plots, liver had only 25% of the concentration of receptor sites per milligram of cytosol protein.
The time course of association and dissociation of receptor-steroid complex at 20C is shown in Fig. 3 . In nine experiments of this type with lung specimens from human fetuses between 17 and 43 wk gestational age, the mean time to reach equilibrium in the forward reaction was 13.5 h (range 8-24 h). Similar rates of receptorsteroid association were found with cytosol of human fetal liver (data not presented). The rate of receptor- steroid association at 20C in these fetal human tissues is slow compared to HTC cells (13) and fetal rabbit lung (9) under similar conditions. These experiments were performed with a [8H]dexamethasone concentration of 20 nM, which is near the half-saturating concentration for many of the receptor preparations. The rate of reaction increased with higher concentrations of hormone and decreased when lower steroid concentrations were used. In one experiment, for example, the times to reach half-equilibrium values at dexamethasone concentrations of 6, 24, and 72 nM were 5.2, 1.6, and 0.8 h, respectively. These results are consistent with a secondorder binding reaction and confirm findings in other systems.
To evaluate the reverse reaction (i.e., dissociation of receptor-steroid complex) we added a 1000-fold excess of unlabeled dexamethasone to one-half of a reaction system that had reached equilibrium. A control sample received only solvent. The amount of labeled dexamethasone bound to receptor was then determined at intervals, as shown in Fig. 3 . Dissociation of the complex is much slower than the forward reaction, consistent with the high affinity of human lung receptor for dexamethasone. In four experiments the mean ti at 20C was 33.5 h (range [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] (9, 13) , suggesting that the glucocorticoid receptors from these different sources have similar binding properties.
The nature of the macromolecular receptor in lung cytosol was investigated in terms of its susceptibility to various hydrolytic enzymes. Cytosol prepared from the lung of a 26-wk gestation fetus was incubated at SoC for 1 h with various enzymes (0.5 mg/ml), and the capacity to bind dexamethasone was then determined. Deoxyribonuclease and ribonuclease had little effect on the concentration of receptor sites; however, the proteolytic enzymes trypsin, pronase, and collagenase (containing protease activity) abolished binding activity. These results suggest that the cytoplasmic glucocorticoid receptor in fetal human lung, like those macromolecules in certain other target tissues (11) (12) (13) 16) , is a protein.
Concentration of receptor sites in cytosol of lung and other fetal tissues. In evaluating the ontogeny of receptor activity in human lung, it was important to determine how various storage conditions affected the concentration of binding sites. Full activity was retained in fresh lung tissue left for up to 36 h at 20C in phosphate-buffered saline; however, there was a variable loss (17-67% of original value) of activity in samples of cytosol stored under similar conditions. Notably, receptor complexed with steroid (eg., Fig. 3 ) was considerably more stable (ti = 80-180 h) than unbound receptor under the same conditions, suggesting, as described elsewhere (13) , that binding of hormone stabilizes the receptor molecule. Full activity was retained in most lung samples frozen at -20'C for tip to 10 days; however some samples lost activity after 1 wk, and five specimens frozen at -20'C for 6-32 mo had no detectable receptor. For determinations of receptor site concentration, therefore, specimens of lung were assayed fresh whenever possible and otherwise were frozen no more than 4 days.
Glucocorticoid receptor activity was detected in lung cytosol from fetuses and neonates of gestational age 12-43 wk. The concentration of cytoplasmic receptor in 27 specimens of lung, arranged according to the method of obtaining the tissue, are presented in Fig. 4 . Lungs from nine fetuses delivered by hyslerotomy had a mean Within each of these three groups, which overlap in the range of gestational ages, there was no apparent effect of fetal age on the concentration of receptor sites. Thus, the twofold difference in receptor concentration between young and older fetuses would appear to result from the markedly different conditions of the older fetus before death. Important factors in this regard might include prolonged air breathing, higher cortisol levels, increased pulmonary circulation, and the hypoxemia and stress of a neonatal illness. Receptor concentration was examined in specimens of liver from 10 fetuses (hysterotomy, n = 3; vaginal abortion, n = 4; neonatal demise, n =3) and was detected in every instance that receptor was present in the lung. Scatchard plots of binding data for the liver were linear (eg., Fig. 2 Hysterotomy specimens contained a low concentration of steroids, consistent with the low Kd values found for these lungs. Abortion samples had on the average twice the steroid concentration and specimens obtained from infants dying in the nursery had five times the level of hysterotomy specimens. These differences are reflected in the higher Kd values obtained for dexamethasone binding in the latter groups. Lungs from neonates with IRDS contained over 20 times the average value of endogenous steroids compared with hysterotomy specimens. The extremely high levels in three of these six specimens (47, 61.6, and 104.9 lsg/100 ml) might be sufficient to mask any receptor activity under the standard assay conditions. However, the other three IRDS specimens contained no more steroid than the higher values in the neonatal demise group that had receptor present. This suggests that other factors, in addition to high endogenous steroid concentrations in the lung, are responsible for the apparent absence of receptor activity.
We also determined steroid levels in 17 samples of cytosol prepared from liver (data not shown). In most instances there was close agreement between the values for lung and liver from the same fetus, and mean values for Table IV and the four specimen groups were similar. These results suggest that the accumulation of endogenous corticoids in lungs of sick neonates is secondary to increased levels of circulating steroids rather than to preferential localization in the lung. We tested for inhibitors of in vitro binding activity in lung cytosols from the IRDS group by mixing aliquots with active lung cytosol from a 25-wk gestation fetus. After a preincubation period the amount of binding activity was determined and compared to controls exposed only to buffer solution. It is seen in Table V that three specimens of IRDS lung cytosol each inhibited receptor activity, and that the level of inhibition is proportional to the amount of endogenous steroid present. Two cytosol preparations from non-IRDS fetuses showed less inhibition, consistent with their lower level of steroids. While it is apparent that high levels of steroids in cytosol preparations will lower the apparent receptor concentration under these assay conditions, these data also suggest that there is no additional inhibitory activity present in cytosol of lungs from IRDS patients.
DISCUSSION
We have described the binding of glucocorticoids by a cytoplasmic protein of human fetal and neonatal lung. The specific nature of the binding reaction is indicated by the high affinity for dexamethasone and saturability of binding sites at a relatively low steroid concentration. In addition, there is a specificity for various steroids that correlates with their glucocorticoid potency.
When human lung slices are incubated at 370C with labeled dexamethasone, the radioactivity is bound primarily in the nuclear fraction. This suggests that recep-tor-dexamethasone complex localizes in the nuclei of human fetal lung under these conditions. As in other glucocorticoid receptor systems (9, 10, 12, 14, 15) , this migration is temperature-dependent, suggesting as proposed elsewhere (12, 14) , that activation or modification of the receptor-steroid complex is required before nuclear uptake occurs. A similar temperature dependence was found for in vitro transfer of receptor-steroid conIl)lex of fetal rabbit lung to isolated lung nuclei (9 The data presented here indicate that glucocorticoid receptor is present in human lung from early in fetal life to the end of normal gestation. Thus, the presence of an active receptor system is not the limiting factor in the onset of glucocorticoid responsiveness in the fetal lung. We found no apparent change in receptor concentration with gestational age within each group of specimens. This suggests that the lower concentration of sites found in the neonatal demise group is secondary to conditions associated with extrauterine life or neonatal illness. Since there was a higher level of endogenous steroids in these lungs, it is possible that receptor was partially depleted from the cytoplasm because of nuclear uptake in vivo. We conclude, therefore, that the level of cytoplasmic binding sites is probably constant throughout fetal life. The mean value of 0.24 pmol receptor sites/ mg protein for human lung from hysterotomy specimens is somewhat less than the level found in fetal rabbit lung (0.43) and fetal lamb lung (0.35) (9) . With an average value of 3.5 mg cytosol protein/mg DNA, and assuming 6.5 pg DNA/cell (26) , there are 3,200 cytoplasmic receptor sites/fetal human lung cell as a minimal estimate. This compares with a calculated 2,300 high-affinity nuclear acceptor sites/cell. It is estimated that the mammalian lung contains at least two dozen different cell types. Since most of these cells probably are present in the human fetal lung by 14 wk of gestation (27) , the binding assay in all experiments sampled a heterogeneous cell population. It is not yet known, however, whether every cell type present in human lung contains both components of the glucocorticoid receptor system.
The level of receptor in lungs of two infants dying 4 and 11 days after delivery at term was similar to that found in infants dying shortly after birth. In this regard the human lung resembles the lung of rabbit and sheep and differs from the rat where receptor levels decrease to low levels soon after birth (17) . The maintenance of receptor after birth suggests that cortisol could also affect pulmonary function in the neonatal period.
Receptor was also present in fetal liver, kidney, heart, small intestine, muscle, and skin, although lung consistently demonstrated the highest concentration of binding sites. Kd values for the binding reaction were similar for various tissues, suggesting that a similar receptor is present in many human organs. These findings are the first description, to our knowledge, of the ubiquity of glucocorticoid receptor in tissues of the human fetus. Receptor activity has previously been described in human lymphocytes and leukemic lymphoblasts (28 (19) strongly suggests that exogenous glucocorticoids will stimulate human 'ung development. The presence of an active glucocorticoid receptor system in human fetal lung indicates that this organ indeed has the capacity to respond directly to corticosteroids and is therefore a target tissue for these hormones. Since receptor is present in lung early in gestation, it may be postulated that the effectiveness of corticosteroids in preventing IRDS would be limited only by the degree of morphological maturity (i.e., formation of alveoli) or by the developmental maturity of enzyme systems or other proteins induced by these hormones. One such enzyme could be choline phosphotransferase, which is stimulated in fetal rabbit lungs by cortisol treatment (29) .
The possible role of endogenous glucocorticoids in the normal development of the human lung is still uncertain. At present, there are no data on plasma cortisol levels during the human gestation for comparison with the appearance of surfactant in lung tissue at about the 20th wk (30) and in amniotic fluid around 32 wk of gestation (31) . It does appear likely, however, that endogenous cortisol production could be stimulated in the fetus by various stressful conditions (e.g., intrauterine infection, placental insufficiency, maternal disease, prolonged rupture of membranes, or spontaneous labor); this could accelerate surfactant appearance (32) and serve -as a protective mechanism for premature adaptation to extrauterine life.
